<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-02-25" id="root" itemid="402337" xml:lang="en">
<title>UK: Oxford Molecular to take stake in Cambridge.</title>
<headline>Oxford Molecular to take stake in Cambridge.</headline>
<dateline>LONDON 1997-02-25</dateline>
<text>
<p>Britain's Oxford Molecular Group Plc said it would make an initial cash investment of 0.5 million stg in drug research firm Cambridge Combinatorial.</p>
<p>Oxford would take a stake of 20 percent in the issued ordinary share capital of Cambridge.</p>
<p>Cambridge Combinatorial would also have to offer three further tranches of deferred shares, equivalent to 0.5 million stg, to Oxford Molecular.</p>
<p>Oxford Molecular said the investment was a strategic move to providing a range of integrated drug design services to its pharmaceutical services.</p>
<p>--London newsroom +44 171 542 7717</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-02-25" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-02-25" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="LONDON" />
<dc element="dc.creator.location.country.name" value="UK" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>